Filter
1238
Text search:
drug
resistance
management
program
Featured
Recommendations
128
New Publications
403
Language
Document type
No document type
784
Studies & Reports
162
Guidelines
161
Manuals
49
Strategic & Response Plan
42
Training Material
21
Fact sheets
9
Situation Updates
7
Brochures
1
Resource Platforms
1
Infographics
1
Countries / Regions
India
70
Kenya
51
Ethiopia
46
Tanzania
36
Uganda
32
Nepal
32
Global
31
South Africa
30
Liberia
27
Zambia
26
Latin America and the Carribbean
25
Philippines
24
Malawi
24
Sierra Leone
23
Rwanda
22
Bangladesh
21
Nigeria
20
Eastern Europe
18
Myanmar / Burma
17
Western and Central Europe
17
Zimbabwe
15
Cambodia
15
Namibia
15
Ghana
13
Indonesia
12
Asia
12
Lesotho
11
Ukraine
10
Africa
10
Mozambique
9
South–East Asia Region
8
Senegal
7
Cameroon
7
Botswana
7
Pakistan
6
Thailand
6
Russia
6
Burkina Faso
5
Congo, Democratic Republic of
5
Eswatini/ Swaziland
5
Venezuela
5
Vietnam
5
Guinea
4
USA
4
Haiti
4
West and Central Africa
4
Middle East and North Africa
4
Albania
4
Georgia
4
Afghanistan
3
Syria
3
China
3
Sri Lanka
3
Bhutan
3
Laos
3
Iran
3
North America
3
Mali
2
Jordan
2
Lebanon
2
Papua New Guinea
2
Sudan
2
Central African Republic
2
Argentina
2
North Macedonia
2
Colombia
2
El Salvador
2
East and Southern Africa
2
Timor Leste/ East Timor
2
Tajikistan
2
Saudi Arabia
1
Somalia
1
South Sudan
1
Iraq
1
Chad
1
Benin
1
Dominican Republic
1
Peru
1
Brazil
1
Switzerland
1
Honduras
1
Ecuador
1
Libya
1
Guatemala
1
Mexico
1
Nicaragua
1
Yemen
1
Western Pacific Region
1
Paraguay
1
Fiji
1
Armenia
1
Canada
1
Qatar
1
Moldova
1
Turkmenistan
1
Maldives
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
583
Clinical Guidelines
83
Public Health
56
Women & Child Health
29
Key Resources
29
Capacity Building
16
Pharmacy & Technologies
16
Toolboxes
TB
189
HIV
140
AMR
128
Mental Health
50
NTDs
37
Malaria
32
Pharmacy
31
COVID-19
21
Caregiver
20
Planetary Health
17
NCDs
17
Rapid Response
14
Ebola & Marburg
12
Health Financing Toolbox
10
2.0 Rapid Response
9
Conflict
7
Cholera
6
Polio
6
Disability
4
Natural Hazards
4
Refugee
4
Global Health Education
4
Zika
3
Social Ethics
1
Для создания этого отчета MSF исследовала программы и практику лечения лекарственно-чувствительного и лекарственно-устойчивого туберкулеза в восьмистранах с высо
...
BMC Infectious Diseases 2012, 12:352/1471-2334/12/352
Resumen para Equipos de Salud Edición 2021-2022
Las presentes recomendaciones se encuentran dirigidas a los miembros del equipo de salud que asisten niñas, niños y adolescentes (NNyA) que viven con VIH. También se dirigen a los responsables jurisdiccionales que participan en el proceso de gesti
...
Polymerase Chain Reaction (PCR) has significantly helped in early diagnosis and commencement of specific interventions for diseases control. It also plays a critical role in understanding the disease epidemiology and unraveling the transmission dynamics of the disease. This manual intends to p
...
Informe sobre poblicationes clave.
In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access TB treatment of questionable quality from public and private providers who are not engaged by the NTP. The quality of care provided i
...
Preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups
recommended
Treating children infected with intestinal worms is one of the simplest and most cost–effective ways to improve their health.
The recommendations are intended for a wide audience, including policy-makers and their expert advisers as well as technical and programme staff at government institution
...
WHO/HTM/TB/2007.384a
“TB is too often a death sentence for people with AIDS.
It does not have to be this way.”
-Nelson Mandela, International conference on HIV /AIDS, Bangkok, Thailand, July 2004
Lancet 2013; 381: 1405–16
Series: Childhood Pneumonia and Diarrhoea no.1
The aim of the meeting was to broaden the network’s initiatives. Preliminary work involved integrating laboratory testing for skin NTDs other than Buruli ulcer, such as cutaneous leishmaniasis, mycetoma, leprosy and yaws, while extending the network’s reach to encompass additional laboratories.
Accessed Febr. 6, 2020
FOLLOW-UP TO THE 2011 POLITICAL DECLARATION ON HIV/AIDS: INTENSIFYING EFFORTS TO ELIMINATE HIV/AIDS | Reporting Period: January – December 2014